Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab in non-infectious uveitis (SUPPORT)
NCT01327664Phase 3Withdrawn
- Sponsor
- Novartis
- Start
- Mar 2011
- Primary completion
- May 2014
01
Overview
A Phase 3 trial of secukinumab in non-infectious intermediate uveitis, Posterior uveitis (non-infectious), non-infectious panuveitis (NIU), sponsored by Novartis. Planned start Mar 2011; status: withdrawn.
02
Drugs
secukinumab
03
Conditions
non-infectious intermediate uveitisPosterior uveitis (non-infectious)non-infectious panuveitis (NIU)
Beyond the preview
Go deeper on NCT01327664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327664.